drug
(doravirine + lamivudine + tenofovir disoproxil fumarate)
Marketedupdated 3mo agoby Merck Sharp & Dohme Corp (Inactive)
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
all catalysts(7)
approval · 7
Aug 30, 2018
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Sep 19, 2019
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Oct 10, 2019
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Jan 27, 2022
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Nov 7, 2024
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Jun 12, 2025
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Oct 29, 2025
approval
$MRK135.84+0.21%
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Trials studying (doravirine + lamivudine + tenofovir disoproxil fumarate)
- phase2DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
- phase3A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy
- phase4The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 30, 2032
~6.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Nov 29, 2036formulationUS 10603282
- Nov 29, 2036formulationUS 10842751
- Aug 30, 2032compositionUS 8486975
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that